Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015, 18.36

Consuming brown rice stalls metastatic tumor progression: Germinated brown rice inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 19/March/2015, 18.14
March 19, 2015
Turning on senescence turns off cancer progression: ATRA, a derivative of Vitamin-A, induces telomere dysfunction and senescence via down regulation of Telomeric repeat binding factor 2 (TRF2), 19/March/2015, 18.57
March 19, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, that Campothecin (CPT), by increasing the expression of its target gene, it may cause early pregnancy loss and fetal growth restriction. Thus, physicians may take this finding into consideration while treating pregnant women with Campothecin.

CitationBoominathan,  Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015,  18.36, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Campothecin (CPT) causes early pregnancy loss and fetal growth restriction

* Research cooperation

Comments are closed.